-
1
-
-
79951934803
-
Annual report on progress against cancer from the American Society of Clinical Oncology
-
Clinical Cancer Advances 10.1200/JCO.2010.33.2742 21060039
-
Kris MG, Benowitz SI, Adams S, Diller L, Ganz P, Kahlenberg MS, Le QT, Markman M, Masters GA, Newman L, Obel JC, Seidman AD, Smith SM, Vogelzang N, Petrelli NJ, Clinical Cancer Advances (2010) Annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol 28(36):5327-5347
-
(2010)
J Clin Oncol
, vol.28
, Issue.36
, pp. 5327-5347
-
-
Kris, M.G.1
Benowitz, S.I.2
Adams, S.3
Diller, L.4
Ganz, P.5
Kahlenberg, M.S.6
Le, Q.T.7
Markman, M.8
Masters, G.A.9
Newman, L.10
Obel, J.C.11
Seidman, A.D.12
Smith, S.M.13
Vogelzang, N.14
Petrelli, N.J.15
-
2
-
-
77949264996
-
Advanced pancreatic carcinoma: Current treatment and future challenges
-
1:CAS:528:DC%2BC3cXisFemsbo%3D 20101258
-
Stathis A, Moore MJ (2010) Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 7(3):163-172
-
(2010)
Nat Rev Clin Oncol
, vol.7
, Issue.3
, pp. 163-172
-
-
Stathis, A.1
Moore, M.J.2
-
3
-
-
77951755278
-
Pancreatic cancer
-
1:CAS:528:DC%2BC3cXlsV2ns7o%3D 20427809
-
Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362(17):1605-1617
-
(2010)
N Engl J Med
, vol.362
, Issue.17
, pp. 1605-1617
-
-
Hidalgo, M.1
-
4
-
-
8244254377
-
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
-
1:CAS:528:DyaK2sXlsFKksLY%3D 9196156
-
Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15(6):2403-2413
-
(1997)
J Clin Oncol
, vol.15
, Issue.6
, pp. 2403-2413
-
-
Burris, H.A.1
Moore, M.J.2
Andersen, J.3
Green, M.R.4
Rothenberg, M.L.5
Modiano, M.R.6
Cripps, M.C.7
Portenoy, R.K.8
Storniolo, A.M.9
Tarassoff, P.10
Nelson, R.11
Dorr, F.A.12
Stephens, C.D.13
Von Hoff, D.D.14
-
5
-
-
20644464360
-
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: Results of a GERCOR and GISCAD phase III trial
-
1:CAS:528:DC%2BD2MXlsVyhsrg%3D 15908661
-
Louvet C, Labianca R, Hammel P, Lledo G, Zampino MG, André T, Zaniboni A, Ducreux M, Aitini E, Taïeb J, Faroux R, Lepere C, de Gramont A (2005) Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol 23(15):3509-3516
-
(2005)
J Clin Oncol
, vol.23
, Issue.15
, pp. 3509-3516
-
-
Louvet, C.1
Labianca, R.2
Hammel, P.3
Lledo, G.4
Zampino, M.G.5
André, T.6
Zaniboni, A.7
Ducreux, M.8
Aitini, E.9
Taïeb, J.10
Faroux, R.11
Lepere, C.12
De Gramont, A.13
-
6
-
-
34948888231
-
Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: Pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study
-
Heinemann V, Labianca R, Hinke A, Louvet C (2007) Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study. Ann Oncol 10:1652-1659
-
(2007)
Ann Oncol
, vol.10
, pp. 1652-1659
-
-
Heinemann, V.1
Labianca, R.2
Hinke, A.3
Louvet, C.4
-
7
-
-
77950498286
-
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: The GIP-1 study
-
1:CAS:528:DC%2BC3cXmtVyhuro%3D 20194854
-
Colucci G, Labianca R, Di Costanzo F, Gebbia V, Cartenì G, Massidda B, Dapretto E, Manzione L, Piazza E, Sannicolò M, Ciaparrone M, Cavanna L, Giuliani F, Maiello E, Testa A, Pederzoli P, Falconi M, Gallo C, Di Maio M, Perrone F (2010) Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. J Clin Oncol 28(10):1645-1651
-
(2010)
J Clin Oncol
, vol.28
, Issue.10
, pp. 1645-1651
-
-
Colucci, G.1
Labianca, R.2
Di Costanzo, F.3
Gebbia, V.4
Cartenì, G.5
Massidda, B.6
Dapretto, E.7
Manzione, L.8
Piazza, E.9
Sannicolò, M.10
Ciaparrone, M.11
Cavanna, L.12
Giuliani, F.13
Maiello, E.14
Testa, A.15
Pederzoli, P.16
Falconi, M.17
Gallo, C.18
Di Maio, M.19
Perrone, F.20
more..
-
8
-
-
0037099604
-
Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer
-
1:CAS:528:DC%2BD38XmtVCrtbs%3D 12118027
-
Maisey N, Chau I, Cunningham D, Norman A, Seymour M, Hickish T, Iveson T, O'Brien M, Tebbutt N, Harrington A, Hill M (2002) Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer. J Clin Oncol 20(14):3130-3136
-
(2002)
J Clin Oncol
, vol.20
, Issue.14
, pp. 3130-3136
-
-
Maisey, N.1
Chau, I.2
Cunningham, D.3
Norman, A.4
Seymour, M.5
Hickish, T.6
Iveson, T.7
O'Brien, M.8
Tebbutt, N.9
Harrington, A.10
Hill, M.11
-
9
-
-
33646155340
-
Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: Results from two randomised controlled trials
-
1:CAS:528:DC%2BD28XjsFaks74%3D 16622436
-
Chau I, Cunningham D, Russell C, Norman AR, Kurzawinski T, Harper P, Harrison P, Middleton G, Daniels F, Hickish T, Prendeville J, Ross PJ, Theis B, Hull R, Walker M, Shankley N, Kalindjian B, Murray G, Gillbanks A, Black J (2006) Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials. Br J Cancer 94(8):1107-1115
-
(2006)
Br J Cancer
, vol.94
, Issue.8
, pp. 1107-1115
-
-
Chau, I.1
Cunningham, D.2
Russell, C.3
Norman, A.R.4
Kurzawinski, T.5
Harper, P.6
Harrison, P.7
Middleton, G.8
Daniels, F.9
Hickish, T.10
Prendeville, J.11
Ross, P.J.12
Theis, B.13
Hull, R.14
Walker, M.15
Shankley, N.16
Kalindjian, B.17
Murray, G.18
Gillbanks, A.19
Black, J.20
more..
-
10
-
-
34250180939
-
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: A randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
-
Swiss Group for Clinical Cancer Research Central European Cooperative Oncology Group 10.1200/JCO.2006.09.0886 1:CAS:528:DC%2BD2sXnsVShtbw%3D 17538165
-
Herrmann R, Bodoky G, Ruhstaller T, Glimelius B, Bajetta E, Schüller J, Saletti P, Bauer J, Figer A, Pestalozzi B, Köhne CH, Mingrone W, Stemmer SM, Tàmas K, Kornek GV, Koeberle D, Cina S, Bernhard J, Dietrich D, Scheithauer W, Swiss Group for Clinical Cancer Research, Central European Cooperative Oncology Group (2007) Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group. J Clin Oncol 25(16):2212-2217
-
(2007)
J Clin Oncol
, vol.25
, Issue.16
, pp. 2212-2217
-
-
Herrmann, R.1
Bodoky, G.2
Ruhstaller, T.3
Glimelius, B.4
Bajetta, E.5
Schüller, J.6
Saletti, P.7
Bauer, J.8
Figer, A.9
Pestalozzi, B.10
Köhne, C.H.11
Mingrone, W.12
Stemmer, S.M.13
Tàmas, K.14
Kornek, G.V.15
Koeberle, D.16
Cina, S.17
Bernhard, J.18
Dietrich, D.19
Scheithauer, W.20
more..
-
11
-
-
73949135518
-
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer
-
1:CAS:528:DC%2BC3cXhtVWitrc%3D 19858379
-
Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W, Harper PG, Dunn J, Tudur-Smith C, West J, Falk S, Crellin A, Adab F, Thompson J, Leonard P, Ostrowski J, Eatock M, Scheithauer W, Herrmann R, Neoptolemos JP (2009) Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol 27(33):5513-5518
-
(2009)
J Clin Oncol
, vol.27
, Issue.33
, pp. 5513-5518
-
-
Cunningham, D.1
Chau, I.2
Stocken, D.D.3
Valle, J.W.4
Smith, D.5
Steward, W.6
Harper, P.G.7
Dunn, J.8
Tudur-Smith, C.9
West, J.10
Falk, S.11
Crellin, A.12
Adab, F.13
Thompson, J.14
Leonard, P.15
Ostrowski, J.16
Eatock, M.17
Scheithauer, W.18
Herrmann, R.19
Neoptolemos, J.P.20
more..
-
12
-
-
53049086773
-
Phase i study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies
-
1:STN:280:DC%2BD1cnhslKruw%3D%3D 18534963
-
Tan BR, Brenner WS, Picus J, Marsh S, Gao F, Fournier C, Fracasso PM, James J, Yen-Revollo JL, McLeod HL (2008) Phase I study of biweekly oxaliplatin, gemcitabine and capecitabine in patients with advanced upper gastrointestinal malignancies. Ann Oncol 19(10):1742-1748
-
(2008)
Ann Oncol
, vol.19
, Issue.10
, pp. 1742-1748
-
-
Tan, B.R.1
Brenner, W.S.2
Picus, J.3
Marsh, S.4
Gao, F.5
Fournier, C.6
Fracasso, P.M.7
James, J.8
Yen-Revollo, J.L.9
McLeod, H.L.10
-
13
-
-
78649490178
-
Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): A phase I/II trial
-
1:STN:280:DC%2BC3cbotFCrtw%3D%3D 20444846
-
Hess V, Pratsch S, Potthast S, Lee L, Winterhalder R, Widmer L, Cescato C, Lohri A, Jost L, Stillhart P, Pestalozzi B, Herrmann R (2010) Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial. Ann Oncol 21(12):2390-2395
-
(2010)
Ann Oncol
, vol.21
, Issue.12
, pp. 2390-2395
-
-
Hess, V.1
Pratsch, S.2
Potthast, S.3
Lee, L.4
Winterhalder, R.5
Widmer, L.6
Cescato, C.7
Lohri, A.8
Jost, L.9
Stillhart, P.10
Pestalozzi, B.11
Herrmann, R.12
-
14
-
-
84886741654
-
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine
-
Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, Harris M, Reni M, Dowden S, Laheru D, Bahary N, Ramanathan RK, Tabernero J, Hidalgo M, Goldstein D, Van Cutsem E, Wei X, Iglesias J, Renschler MF (2013) Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 369(18):1691-1703
-
(2013)
N Engl J Med
, vol.369
, Issue.18
, pp. 1691-1703
-
-
Von Hoff, D.D.1
Ervin, T.2
Arena, F.P.3
Chiorean, E.G.4
Infante, J.5
Moore, M.6
Seay, T.7
Tjulandin, S.A.8
Ma, W.W.9
Saleh, M.N.10
Harris, M.11
Reni, M.12
Dowden, S.13
Laheru, D.14
Bahary, N.15
Ramanathan, R.K.16
Tabernero, J.17
Hidalgo, M.18
Goldstein, D.19
Van Cutsem, E.20
Wei, X.21
Iglesias, J.22
Renschler, M.F.23
more..
-
15
-
-
79955921754
-
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
-
Groupe Tumeurs Digestives of Unicancer PRODIGE Intergroup 10.1056/NEJMoa1011923 1:CAS:528:DC%2BC3MXlvF2jsrw%3D 21561347
-
Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M, Groupe Tumeurs Digestives of Unicancer, PRODIGE Intergroup (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364(19):1817-1825
-
(2011)
N Engl J Med
, vol.364
, Issue.19
, pp. 1817-1825
-
-
Conroy, T.1
Desseigne, F.2
Ychou, M.3
Bouché, O.4
Guimbaud, R.5
Bécouarn, Y.6
Adenis, A.7
Raoul, J.L.8
Gourgou-Bourgade, S.9
De La Fouchardière, C.10
Bennouna, J.11
Bachet, J.B.12
Khemissa-Akouz, F.13
Péré-Vergé, D.14
Delbaldo, C.15
Assenat, E.16
Chauffert, B.17
Michel, P.18
Montoto-Grillot, C.19
Ducreux, M.20
more..
-
16
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
-
1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
-
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205-216
-
(2000)
J Natl Cancer Inst
, vol.92
, Issue.3
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
Verweij, J.7
Van Glabbeke, M.8
Van Oosterom, A.T.9
Christian, M.C.10
Gwyther, S.G.11
-
17
-
-
0016725211
-
The McGill Pain Questionnaire: Major properties and scoring methods
-
1:STN:280:DyaE2s3htlOhsQ%3D%3D 1235985
-
Melzack R (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain 1:277-299
-
(1975)
Pain
, vol.1
, pp. 277-299
-
-
Melzack, R.1
-
19
-
-
0026581068
-
Analgesic use in home hospice cancer patients
-
1:STN:280:DyaK387kvVentQ%3D%3D 1371139
-
McCormack A, Hunter-Smith D, Piotrowski ZH, Grant M, Kubik S, Kessel K (1992) Analgesic use in home hospice cancer patients. J Fam Pract 34:160-164
-
(1992)
J Fam Pract
, vol.34
, pp. 160-164
-
-
McCormack, A.1
Hunter-Smith, D.2
Piotrowski, Z.H.3
Grant, M.4
Kubik, S.5
Kessel, K.6
-
20
-
-
0027417437
-
The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
-
1:STN:280:DyaK3s7msVarsQ%3D%3D 8433390
-
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365-376
-
(1993)
J Natl Cancer Inst
, vol.85
, Issue.5
, pp. 365-376
-
-
Aaronson, N.K.1
Ahmedzai, S.2
Bergman, B.3
Bullinger, M.4
Cull, A.5
Duez, N.J.6
Filiberti, A.7
Flechtner, H.8
Fleishman, S.B.9
De Haes, J.C.10
-
21
-
-
0031972496
-
Interpreting the significance of changes in health-related quality-of-life scores
-
1:STN:280:DyaK1c7gtFKrtw%3D%3D 9440735
-
Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139-144
-
(1998)
J Clin Oncol
, vol.16
, Issue.1
, pp. 139-144
-
-
Osoba, D.1
Rodrigues, G.2
Myles, J.3
Zee, B.4
Pater, J.5
-
22
-
-
0024536437
-
Optimal two-stage designs for phase II clinical trials
-
1:STN:280:DyaL1M7ps1SjsQ%3D%3D 2702835
-
Simon R (1989) Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10:1-10
-
(1989)
Control Clin Trials
, vol.10
, pp. 1-10
-
-
Simon, R.1
-
23
-
-
73949107880
-
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment
-
Philip PA, Mooney M, Jaffe D, Eckardt G, Moore M, Meropol N, Emens L, O'Reilly E (2009) Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. J Clin Oncol 27:5660-5669
-
(2009)
J Clin Oncol
, vol.27
, pp. 5660-5669
-
-
Philip, P.A.1
Mooney, M.2
Jaffe, D.3
Eckardt, G.4
Moore, M.5
Meropol, N.6
Emens, L.7
O'Reilly, E.8
-
24
-
-
84905650613
-
Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomized controlled trials
-
Li Q, Yan H, Liu W, Zhen H, Yang Y, Cao B (2014) Efficacy and safety of gemcitabine-fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized controlled trials. PLoS One 9(8):e104346
-
(2014)
PLoS One
, vol.9
, Issue.8
, pp. 104346
-
-
Li, Q.1
Yan, H.2
Liu, W.3
Zhen, H.4
Yang, Y.5
Cao, B.6
-
25
-
-
58049194302
-
Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: A pooled analysis of randomized trials
-
1:CAS:528:DC%2BD1MXhs1GgurY%3D 19018087
-
Arkenau HT, Arnold D, Cassidy J, Diaz-Rubio E, Douillard JY, Hochster H, Martoni A, Grothey A, Hinke A, Schmiegel W, Schmoll HJ, Porschen R (2008) Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials. J Clin Oncol 26(36):5910-5917
-
(2008)
J Clin Oncol
, vol.26
, Issue.36
, pp. 5910-5917
-
-
Arkenau, H.T.1
Arnold, D.2
Cassidy, J.3
Diaz-Rubio, E.4
Douillard, J.Y.5
Hochster, H.6
Martoni, A.7
Grothey, A.8
Hinke, A.9
Schmiegel, W.10
Schmoll, H.J.11
Porschen, R.12
|